Normal Liver Ultrasound But High FIB-4: Why This Happens
Why a normal abdominal ultrasound and a high FIB-4 score (or elevated liver stiffness on elastography) often coexist — and what it means for next steps.
A common scenario in primary care: a patient has a routine abdominal ultrasound that comes back 'normal' or shows only mild fatty changes — but their FIB-4 score is elevated, or a subsequent elastography scan shows a higher-than-expected kPa value. This article explains why that mismatch is not a contradiction, and why standard ultrasound is not the right tool for assessing fibrosis.
What standard ultrasound actually shows
Conventional abdominal ultrasound is excellent at imaging liver structure, identifying gallstones, characterising focal lesions, and detecting moderate-to-severe steatosis (fatty liver). It is good at telling you that the liver looks structurally normal.
What it cannot reliably do: detect early-to-moderate fibrosis. The liver can be significantly scarred internally without any change in shape, size, or echotexture that's visible on a standard B-mode scan. Until cirrhosis is advanced — coarse echotexture, surface nodularity, splenomegaly, portal hypertension features — standard ultrasound usually appears 'normal.'
What FIB-4 and elastography measure
FIB-4 is a blood test score (age, AST, ALT, platelets) that estimates the probability of advanced fibrosis. A FIB-4 above 1.3 in patients under 65 (or above 2.0 in patients ≥65) is considered raised — the indeterminate or 'consider further testing' zone.
Elastography directly measures liver stiffness, which correlates with fibrosis. A kPa above 8 in MAFLD context typically indicates significant fibrosis worth specialist review. Neither of these tests is asking the same question as a standard ultrasound.
Why the tests can disagree
Standard ultrasound: structure. FIB-4: probability of advanced scarring based on blood markers. Elastography: actual stiffness measurement. They measure different things, so a 'normal ultrasound' alongside a 'raised FIB-4' simply means there is no obvious structural problem visible to the eye, but the blood markers and/or the tissue stiffness suggest underlying fibrosis that the eye cannot see.
This is exactly why guidelines moved away from relying on standard ultrasound for fibrosis staging. Ultrasound remains essential for ruling out structural disease and assessing fatty liver — but it is not a fibrosis test.
What to do with the mismatch
The right approach: trust the more specific test for the question being asked. If the question is 'does my liver have significant scarring?' — the answer comes from elastography, not from the structural ultrasound report.
Patients with normal ultrasound but raised FIB-4 should usually proceed to elastography. If elastography is also high, specialist review is appropriate. If elastography is reassuring, the FIB-4 is likely a false-positive driven by age, transient ALT elevation, or other factors — and routine annual monitoring is reasonable.